))
Navigating Independence: Insights into Consulting, Small Business, and Drug Development with Jeff Fielhauer
Arkistoidut sarjat ("Toimeton syöte" status)
When?
This feed was archived on May 28, 2024 13:08 (
Why? Toimeton syöte status. Palvelimemme eivät voineet hakea voimassa olevaa podcast-syötettä tietyltä ajanjaksolta.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 406076441 series 3556911
Sisällön tarjoaa sheilapodcast2024. sheilapodcast2024 tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Drug sponsors face challenges with independent consultants. Jeff Fielhauer of Greenforce Medical Writing discusses the corporate ladder's limitations and the perks of small businesses, covering incorporation, tax considerations, & 1099 vs. W2 economics. He refutes the notion that consultants are pricier than full-time employees. Topics include various contracts, working with small vs. large pharma, and AI's impact on drug development, and more!
2 jakso
Jaa
